ReviewNeurology2024
Understanding Diversity, Equity, and Inclusion Roles in Academic Neurology Departments.
Abstract readReview
In one paragraph
Review in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Andrew R SpectorFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.ORCID 0000-0003-4645-1205
Nimish A MohileFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Madeline ChadehumbeFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Raina CroffFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Charles C Flippen IiFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Camilo A GutierrezFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Roy H HamiltonFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.ORCID 0000-0001-8400-0726
Rodney LeacockFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Teshamae S MonteithFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.ORCID 0000-0001-8912-252X
Cumara O'CarrollFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.ORCID 0000-0002-1115-7949
Alice RutatangwaFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Reena P ThomasFrom the Department of Neurology (A.R.S.), Duke University School of Medicine, Durham, NC; Department of Neurology (N.A.M.), University of Rochester School of Medicine and Dentistry, NY; NeurAbilities Healthcare (M.C.), Voorhees, NJ; Department of Neurology (R.C.), Oregon Health Sciences University School of Medicine, Portland; Department of Neurology (C.C.F.I.), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (C.A.G.), University of Maryland School of Medicine, Baltimore; Department of Neurology (R.H.H.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Prisma Health (R.L.); Department of Neurology (T.S.M.), University of Miami Miller School of Medicine, FL; Department of Neurology (C.O.C.), Mayo Clinic Alix School of Medicine, Scottsdale, AZ; Department of Neurology (A.R.), University of California San Francisco School of Medicine; and Department of Neurology (R.P.T.), Stanford University School of Medicine, Palo Alto, CA.
Funding
Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zachary Beattie · 2020 to 2026
$28.6MNIA NIH HHS P30 AG066518
Abstract
Academic neurology departments across the country have been rapidly adding diversity, equity, and inclusion (DEI) programs over the past 5-10 years. These programs frequently come with leadership roles that carry a variety of names and responsibilities, such as vice chair of DEI or diversity officer. Furthermore, there are roles for members of the department to be involved with DEI work without being designated the departmental DEI leader. This article provides a framework for understanding the different responsibilities that are typically associated with each of these roles, along with reasonable expectations to associate with the respective job titles. Our goal is to prevent departments from asking too much or expecting too little based on the job title and support provided to the people in these positions. Likewise, we hope to empower DEI leaders who are currently asked to perform duties beyond their scope to obtain the title and support they have earned. For each departmental DEI role, we review prerequisites to success and potential impediments.
Indexed as
Academic Medical CentersCultural DiversityLeadershipNeurologyFaculty, MedicalHumansSocial Inclusion
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.